DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc (the “Company”) today announced the limited commercial launch in the U.S. of ReActiv8, its implantable Restorative Neurostimulation™ system to ...

The one-year results show sustained performance in the ReActiv8-A Clinical Trial at the one-year follow-up with a clinically important, statistically significant and lasting improvement in the study’s ...

"This recognition belongs to everyone" ...

Mechanical chronic low back pain results from an injury or stress on the tissues surrounding the spine, including soft tissues, muscles, bones, and joints. Often, this type of pain is due to impaired ...

Mainstay Medical Holdings plc, a medical device company focused on commercializing its innovative implantable Restorative Neurostimulation system, ReActiv8, for people with disabling mechanical ...

DUBLIN, February 04, 2026--(BUSINESS WIRE)--Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company's ReActiv8 ...

Anyone living with chronic low back pain frequently has one wish on their mind: “Fix. My. Lower. Back.” Now, a new clinically proven restorative treatment option called ReActiv8 could make a ...

Founded in Minneapolis in 2008, Mainstay moved to Dublin in 2012. The latest funding will help it expand its ReActiv8 product in the US, Europe and Australia. Irish medtech company Mainstay Medical ...

Mainstay Medical has suffered a setback in its efforts to get its ReActiv8 implant approved for therapeutic use in Australia, with regulators requesting additional clinical data. ReActiv8 is an ...

Chronic lower back pain is something that can dramatically affect a person’s lifestyle and wellbeing. Whilst most back pain only lasts a short while and can be treated with medication or physiotherapy ...